Biondo Focus Fund
BFONX
NASDAQ- -
USD
- -
- -
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Sector
- Financial Services
- Industry
- Asset Management
- Address
- Hauppauge, NY 11788 United States of America
- IPO Date
- Mar 19, 2010
- CIK
- 0001314414
- Website
- thebiondogroup.com
- Similar Companies
- Business
- Biondo Focus Fund (BFONX) is an open-end mutual fund that seeks long-term capital appreciation through a high-conviction, concentrated portfolio typically comprising 15 to 30 holdings in growth-oriented companies. The fund invests primarily in long positions in common stocks of U.S. companies of any market capitalization, American depositary receipts representing foreign companies, investment grade fixed income securities rated Baa3 or higher by Moody's or BBB- or higher by S&P, exchange-traded funds focused on U.S. stocks, ADRs or investment grade fixed income, and options on common stocks, ADRs and ETFs; it targets companies with exceptional growth prospects, quality management, niche business segments and high barriers to entry, while employing leverage up to 33% of assets via bank borrowing, covered call writing, option strategies and warrants to enhance returns. Launched in March 2010 and domiciled in the United States, the fund is advised by Biondo Investment Advisors, LLC, a boutique wealth management firm wholly owned by The Biondo Group, LLC and headquartered at 544 Routes 6 & 209, PO Box 909, Milford, Pennsylvania 18337, with a satellite office in Sparta, New Jersey; it is distributed by Northern Lights Distributors, LLC and administered by Ultimus Fund Solutions, LLC, with portfolio management led by Joseph P. Biondo since inception and Scott Goginsky since December 2018. The fund maintains a large growth investment style, with approximately 90.82% in U.S. stocks, 8.60% in non-U.S. stocks and minimal cash, focusing on sectors such as technology (51.80%), healthcare (24.13%) and financial services (14.72%), primarily serving U.S. investors through brokerage platforms including UBS, Fidelity and Charles Schwab, with a minimum initial investment of $1,000 and net expense ratio of 1.50%. In recent developments, the adviser has contractually agreed to waive fees and reimburse expenses through at least April 30, 2026 to cap total annual operating expenses; as of late 2025, assets under management stand at around $50.91 million, with top holdings including NVIDIA Corp. (17.23%), Mastercard Inc. (14.72%) and Intuitive Surgical Inc. (12.64%), reflecting continued emphasis on high-growth technology and healthcare names amid market volatility.